Hirofumi Shirakawa
Utsunomiya, 3200834, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Randomized phase III trial of gemcitabine plus nab-paclitaxel versus gemcitabine plus S-1 as neoadjuvant chemotherapy for resectable pancreatic cancer in geriatric patients: JCOG2101C (PRESTIGE study).
Journal: Japanese journal of clinical oncology
Published: January 06, 2026
High Immunohistochemical Expression of SETD5 as a Candidate Pathological Factor for Dedifferentiation and Prognosis in Liposarcoma.
Journal: Pathology international
Published: August 21, 2025
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 28, 2025
Original Study: Risk Factors for Early Recurrence in Patients With Biliary Tract Cancers Who Underwent Curative Resection: An Exploratory Subgroup Analysis of JCOG1202.
Journal: Journal of surgical oncology
Published: June 10, 2025
Neoadjuvant Chemotherapy With Gemcitabine and S-1 Versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II/III Prep-02/JSAP05 Trial.
Journal: Annals of surgery
Published: April 16, 2025
Impact of ERCC1 on the outcomes of chemotherapy in advanced biliary tract cancer.
Journal: Scientific reports
Published: January 01, 2025
5-Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S-1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1).
Journal: Journal of hepato-biliary-pancreatic sciences
Published: September 25, 2024
Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021-22.
Journal: Japanese journal of clinical oncology
Published: March 13, 2024
Early tumor shrinkage as a prognostic predictor in chemotherapy-naïve patients with locally advanced pancreatic cancer treated with modified FOLFIRINOX or gemcitabine plus nab-paclitaxel combination therapy: An exploratory analysis of JCOG1407.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: February 08, 2024
Development of a nomogram to predict survival in advanced biliary tract cancer.
Journal: Scientific reports
Published: June 29, 2023
Last Updated: 09/26/2026